Evidence map›Paper›PMID 39338190›Full record

ArticleJournal of personalized medicine2024

RETRACTED: Determinants of Disease Progression in Autosomal Dominant Polycystic Kidney Disease.

Molla Asnake Kebede, Yewondwosen Tadesse Mengistu, Biruk Yacob Loge, Misikr Alemu Eshetu, Erkihun Pawlos Shash, Amenu Tolera Wirtu, Jickssa Mulissa Gemechu

RetractedAbstract readRetracted Publication
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of personalized medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Molla Asnake KebedeDepartment of Internal Medicine, School of Medicine, College of Medicine and Health Science, Mizan-Tepi University, Mizan-Aman P.O. Box 260, Ethiopia.
Yewondwosen Tadesse MengistuDepartment of Nephrology, College of Health Sciences, Addis Ababa University, Addis Ababa P.O. Box 9086, Ethiopia.
Biruk Yacob LogeDurame General Hospital, Internal Medicine Unite, SNNPR, Durame P.O. Box 143, Ethiopia.
Misikr Alemu EshetuDepartment of Internal Medicine, School of Medicine, College of Medicine and Health Science, Mizan-Tepi University, Mizan-Aman P.O. Box 260, Ethiopia.ORCID 0009-0006-4177-3554
Erkihun Pawlos ShashDepartment of Internal Medicine, School of Medicine, College of Medicine and Health Science, Mizan-Tepi University, Mizan-Aman P.O. Box 260, Ethiopia.ORCID 0009-0003-6957-1821
Amenu Tolera WirtuMeritus Medical Center, Meritus School of Osteopathic Medicine, Hagerstown, MD 21742, USA.
Jickssa Mulissa GemechuDepartment of Foundational Medical Studies, Oakland University William Beaumont School of Medicine, Rochester, MI 48309, USA.ORCID 0000-0002-0566-0417

Funding

Addis Ababa University Protocol number 094
6 · The paper itself

Abstract

backgroundDespite its severity, there has been a lack of adequate study on autosomal dominant polycystic kidney disease (ADPKD) in Ethiopia. This study assessed the clinical profile and determinant factors contributing to renal disease progression.

methodsA retrospective study was conducted on 114 patients for 6 years in Addis Ababa. Patients with ADPKD who had follow-up visits at two health centers were included.

resultsThe mean age at diagnosis was 42.7 ± 12.7 years, with 43% reporting a positive family history of ADPKD. Approximately 22 patients (20%) developed end-stage renal disease, and 12 patients died. The mean estimated glomerular filtration rate at the initial visit was 72.4 mL/min/1.73 m

conclusionsThese findings underscore the importance of early detection and management of hypertension and comorbidities in ADPKD patients to mitigate disease progression and improve treatment outcomes.

Indexed as

autosomal dominant polycystic kidney diseaseclinical profiledisease progressionEthiopia

Identifiers

PMID39338190
PMCPMC11433103

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.